PGR and endometrial cancer: The CRISPR-Cas9-sgRNA and the donor vector were co-transfected into two endometrial cancer cell lines, Ishikawa and ECC1 (reported as a derivative of Ishikawa cells [29,30]), to generate the PR reporter gene expressing cells (Figure 1E).